Chinese Medicine Treatment for Afatinib-Induced Paronychia

Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Pei-Yuu, Tai, Chen-Jei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602615/
https://www.ncbi.nlm.nih.gov/pubmed/28948057
http://dx.doi.org/10.1155/2017/7327359
_version_ 1783264589837762560
author Yang, Pei-Yuu
Tai, Chen-Jei
author_facet Yang, Pei-Yuu
Tai, Chen-Jei
author_sort Yang, Pei-Yuu
collection PubMed
description Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.
format Online
Article
Text
id pubmed-5602615
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-56026152017-09-25 Chinese Medicine Treatment for Afatinib-Induced Paronychia Yang, Pei-Yuu Tai, Chen-Jei Case Rep Oncol Med Case Report Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient's condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia. Hindawi 2017 2017-08-29 /pmc/articles/PMC5602615/ /pubmed/28948057 http://dx.doi.org/10.1155/2017/7327359 Text en Copyright © 2017 Pei-Yuu Yang and Chen-Jei Tai. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yang, Pei-Yuu
Tai, Chen-Jei
Chinese Medicine Treatment for Afatinib-Induced Paronychia
title Chinese Medicine Treatment for Afatinib-Induced Paronychia
title_full Chinese Medicine Treatment for Afatinib-Induced Paronychia
title_fullStr Chinese Medicine Treatment for Afatinib-Induced Paronychia
title_full_unstemmed Chinese Medicine Treatment for Afatinib-Induced Paronychia
title_short Chinese Medicine Treatment for Afatinib-Induced Paronychia
title_sort chinese medicine treatment for afatinib-induced paronychia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602615/
https://www.ncbi.nlm.nih.gov/pubmed/28948057
http://dx.doi.org/10.1155/2017/7327359
work_keys_str_mv AT yangpeiyuu chinesemedicinetreatmentforafatinibinducedparonychia
AT taichenjei chinesemedicinetreatmentforafatinibinducedparonychia

Ejemplares similares